News

Avid, a wholly-owned subsidiary of Eli Lilly. Lilly acquired Avid Radiopharmaceuticals in December 2010. Amyvid is a molecular imaging agent under investigation for Positron Emission Tomography (PET) imaging

The company has posted loss from operations of $6.2m, compared to $3.26m for the comparable period in 2009. For the full year ended 31 December 2010, the company

The advancement follows the receiving of $40m by FibroGen from its partner Astellas in the fourth quarter of 2010 under Astellas’ license to rights for the European Union

Xyrem is an oral solution that contains the active substance sodium oxybate (500mg/ml). Xyrem is indicated for the treatment of narcolepsy with cataplexy in adults. UCB said that

Under the agreement, ZBx can exercise its option during a period which starts 90 days from, and expires 120 days after, the effective date of the Option. If

The new coupling methods will greatly expand the technology’s applicability in the key drug discovery and life science research markets. The three new coupling methods, for use with

Under the agreement, Anacor and MMV will work together on the development of AN3661 through human proof-of-concept studies. AN3661 was developed as part of a research agreement signed

Pursuant to the settlement agreement, the parties have agreed to terminate the collaboration agreement. In addition, in consideration of Elite’s agreement to terminate the collaboration agreement and to

Mylan received a report from a pharmacist who had received several bottles of Mylan-Minocycline Capsules, 50 mg, including one bottle that was mislabeled as another product (Mylan-Amlodipine Tablets,